Page last updated: 2024-11-08

cantharidin and Granulocytic Leukemia

cantharidin has been researched along with Granulocytic Leukemia in 2 studies

Cantharidin: A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.
cantharidin : A monoterpenoid with an epoxy-bridged cyclic dicarboxylic anhydride structure secreted by many species of blister beetle, and most notably by the Spanish fly, Lytta vesicatoria. Natural toxin inhibitor of protein phosphatases 1 and 2A.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kok, SH2
Chui, CH2
Lam, WS2
Chen, J2
Lau, FY2
Wong, RS2
Cheng, GY2
Tang, WK2
Cheng, CH2
Tang, JC2
Chan, AS2
Teo, IT1
Cheung, F1

Other Studies

2 other studies available for cantharidin and Granulocytic Leukemia

ArticleYear
Mechanistic insight into a novel synthetic cantharidin analogue in a leukaemia model.
    International journal of molecular medicine, 2006, Volume: 18, Issue:2

    Topics: Adult; Animals; Antineoplastic Agents; Bone Marrow Cells; Cantharidin; Cell Cycle; Cell Line, Tumor;

2006
Apoptogenic activity of a synthetic cantharimide in leukaemia: implication on its structural activity relationship.
    International journal of molecular medicine, 2006, Volume: 18, Issue:6

    Topics: Acute Disease; Apoptosis; Cantharidin; Caspases; Cell Line, Tumor; Cell Survival; Cytotoxicity Tests

2006